Immunocytology improves prognostic impact of peritoneal tumour cell detection compared to conventional cytology in gastric cancer

European Journal of Surgical Oncology

Volumn 25, Issue 5, 1999, Pages 515-519

  Vogel, P ^a   Ruschoff J ^a   Kummel S ^a   Zirngibl, H ^a   Hofstadter F ^a   Hohenberger, W ^b   Jauch, K W ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Gastric cancer; Microscopic peritoneal dissemination; Prognosis

Indexed keywords

ANTIBODY;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL PROCEDURES; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; TUMOR CELL;

EID: 0345425035     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0688     Document Type: Article

References (26)

1. Iitsuka Y, Shiota S, Matsui T, Murata Y, Kimura A, Koga S. Relationship between the cytologic characteristics of intraperitoneal free cancer cells and the prognosis in patients with gastric cancer. Acta Cytol. 34:1990;437-442.
2. Boku T, Nakane Y, Minoura T, Takada H, Yamamura M, Hioki K, Yamamoto M. Prognostic significance of serosal invasions and free intraperitoneal cancer cells in gastric cancer. Br J Surg. 77:1990;436-439.
3. Bonenkamp JJ, Songun I, Hermans J, van der Velde CHJ. Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg. 83:1996;672-674.
4. Abe S, Yoshimura H, Tabara H, Tachibana M, Monden N, Nakamura T, Nagaoka S. Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome. J Surg Oncol. 59:1995;226-229.
5. Akama, F, Kajiwara, K, Ishikawa, H, Minami, H, Nakamura, Y, Cytological examination of abdominal washings in gastric cancer surgery, In: Siewart JR, Roder JD (eds) Progress in Gastric Cancer Research, 1997. Bologna, Italy: Monduzzi Editore S.p.A1997, 321, 3.
6. Nomoto S, Nakao A, Kasai Y, Inoue S, Harada A, Nonami T, Takagi H. Peritoneal washing cytology combined with immunocytochemical staining and detecting mutant K- ras in pancreatic cancer: comparison of the sensitivity and availability of various methods. Pancreas. 14:1997;126-132.
7. Ambrose NS, MacDonald F, Young J, Thompson H, Keighly MRB. Monoclonal antibody and cytological detection of free malignant cells in the peritoneal cavity during resection of colorectal cancer - can monoclonal antibodies do better? Eur J Surg Oncol. 15:1989;99-102.
8. Leather AJM, Kocjan G, Path MRC, Savage F, Hu W, Yiu CY, Boulos PB, Northover JMA, Phillips RKS. Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancer. Dis Colon Rectum. 37:1994;814-819.
9. Spiessl, B, Beahrs, OH, Hermanek, P, Hütter, RVP, Scheibe, D, Sobin, LH, Wagner, G, UICC TNM Atlas. 3rd edn. Berlin, Heidelberg, New York: Springer Verlag, 1993.
10. Ikeguchi M, Oka A, Tsujitani S, Maeta M, Kaibara N. Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer. Anticancer Res. 14:1994;2131-2134.
11. Juhl H, Kalthoff H, Krüger U, Henne-Bruns D, Kremer B. Immunozytologischer Nachweis mikrometastatischer Zellen bei Patienten mit gastrointestinalen Tumouren. Zentralbl Chir. 120:1995;116-122.
12. Broll R, Lembcke K, Stock C, Zingler M, Duchrow W, Schimmenpenning H, Strik M, Müller G, Kujath P, Bruch H-P. Tumourzelldissemination in das Knochenmark und die Peritonealhöhle. Langenbecks Arch Chir. 381:1996;51-58.
13. Juhl H, Stritzel M, Wroblewski A, Henne-Bruns D, Kremer B, Schmiegel W, Neumaier M, Wagener Ch, Schreiber HW, Kalthoff H. Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer. 57:1991;330-335.
14. Los G, McVie JG. Experimental and clinical status of intraperitoneal chemotherapy. Eur J Cancer. 26:1990;755-762.
15. Kelsen D, Karpeh M, Schwartz G, Gerdes H, Lightdale C, Botet J, Lauers G, Klimstra D, Huang Y, Saltz L, Quan V, Brennan M. Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J Clin Oncol. 14:1996;1818-1828.
16. Ikeguchi M, Kondou A, Oka A, Tsujitani S, Maeta M, Kaibara N. Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion. Eur J Surg. 161:1995;581-586.
17. Hiratsuka, M, Furukawa, H, Iwanaga, T, Tamura, S, Yasuda, T, Nakamori, S, Ohigashi, H, Kameyama, M, Sasaki, Y, Kabuto, T, Ishikawa, O, Imaoka, S, Intraperitoneal high-dose chemotherapy with mitomycin C in patients with positive peritoneal lavage cytology, In: Siewert R, Roder J (eds) Progress in Gastric Cancer Research, Vol. 2. Bologna, Italy: Monduzzi Editore S.p.A International Proceedings Division, 1997: 1349-52.
18. Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimara K, Sawa T, Katayama K, Tanaka S, Hirono Y, Miwa K, Miyazaki I. Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg. 19:1995;450-455.
19. Takahashi T, Hagiwara A, Shimotsuma M, Sawai K, Yamaguchi T. Prophylaxis and treatment of peritoneal carcinomatotsis: intraperitoneal chemotherapy with mitomycin C bound activated carbon particles. World J Surg. 19:1995;565-569.
20. Sautner T, Hofbauer F, Depisch D, Schiessel R, Jakesz R. Adjuvant intraperitoneal cisplatin chemotherapy does not improve long term survival after surgery for advanced gastric cancer. J Clin Oncol. 12:1994;970-974.
21. Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer. 73:1994;2048-2052.
22. Simon B, Podolsky DK, Moldenhauer G, Isselbacher KJ, Gattoni Celli S, Brand SJ. Epithelial glycoprotein is a member of a family of epithelial cell surface antigens homologous to nidogen, a matrix adhesion protein. Proc Natl Acad Sci USA. 87:1990;2755-2759.
23. Kuhlmann L, Berghauser KH, Schaffer H. Distinction of mesothelioma from carcinoma in pleural effusions. An immunocytochemical study on routinely processed cytobloc preparations. Pathol Res Pract. 187:1991;467-471.
24. Tupitsyn NN, Kadagidze ZG, Blokhina NG, Baryshnikow A, Ermilova VD, Artamonova EV, Moldenhauer G, Bernard A. The expression of leucocytic and related antigens on the cell of human breast cancer cells. Eksp Onkol. 12:1990;54-58.
25. Gottschalk J, Jautzke G, Zimmer C, Cervos-Navarro J. HEA-125 and BER EP4: two monoclonal anti-epithelial, non cytokeratin antibodies distinguishing metastatic carcinomas from glial tumours. Clin Neuropathol. 12:1993;68-72.
26. Lawrence RJ, Loizidou M, Cooper AJ, Alexander P, Taylor I. Importance of the omentum in the development of intra-abdominal metastases. Br J Surg. 78:1991;117-119.